Lecture

Monoclonal Antibody Therapies: Mechanisms and Targets

Description

This lecture covers the use of monoclonal antibodies in cancer treatment, focusing on targeting specific antigens and immunosuppressive mechanisms. It explains how antibodies like Herceptin and Rituximab work, as well as newer immune checkpoint inhibitors like CTLA-4 and PD-1. The instructor details the mechanisms of action of these antibodies, including activating immune responses, blocking immunosuppression, and inducing cytotoxic effects. The lecture also discusses the role of Tregs and CD8 T cells in tumor-associated immunosuppression, emphasizing the importance of understanding these interactions for developing effective therapies.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.